Artificial Intelligence & Machine Learning Transformation in Healthcare
Andrew Kasarskis, PhD, Executive Vice President and Chief Data Officer of the Mount Sinai Health System, is responsible for supporting the patient care, education, research, and innovation missions of the Mount Sinai Health System, which includes the Icahn School of Medicine at Mount Sinai. His mandate is to create value from the data assets of the large and diverse organization.
From 2011 to 2019, Dr. Kasarskis built the Icahn Institute for Genomics and Multiscale Biology, now the Icahn Institute for Data Science and Genomic Technology as Co-Director with Eric Schadt, PhD. At the same time, he served as Vice Chair of the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. As a Professor in the Department of Genetics and Genomic Sciences and the Icahn Institute, Dr. Kasarskis continues to lead collaborative projects that seek to identify biomarkers from a systems understanding of biology and develop new therapeutics. His research focuses on creating and applying technology to diverse areas, including pathogen surveillance, autoimmune conditions such as inflammatory bowel disease and asthma, viral infections, and primary prevention of chronic disease.
Dr. Kasarskis has two decades of experience managing research and technology development projects in software engineering, drug development, human and mouse genetics, and other biological research applications. Prior to joining Mount Sinai, he was Senior Director at Pacific Biosciences, where he developed medical and research applications for the company’s Single-Molecule Real Time (SMRT) sequencing technology. He served as Scientific Director of Genetics at Merck Research Laboratories and contributed to the launch of Sage Bionetworks, a not-for-profit medical research organization that advances human health by making science more open, collaborative, and inclusive. Additionally, Dr. Kasarskis worked at Stanford University to develop genome databases, including the Gene Ontology, the Stanford Microarray Database, and the Saccharomyces Genome Database. He was also Senior Product Manager for genome databases and software at DoubleTwist, Inc., a genomic information and bioinformatics analysis company.
His published work includes book chapters and peer-reviewed articles spanning the fields of genetics, genomics, systems biology, bioinformatics, infectious disease, sleep, and several human disorders.
Dr. Kasarskis holds a PhD in Molecular and Cellular Biology from UC Berkeley as well as a BS in Biology and a BA in Chemistry from the University of Kentucky.
Mr. Daniel Barchi serves as Chief Information Officer of The New York and Presbyterian Hospital. Mr. Barchi serves as the Chief Executive Officer of Biophile, Inc. Mr. Barchi serves as Senior Vice President of Bridgeport Hospital & Healthcare Services, Inc. Mr. Barchi serves as Chief Information Officer of Yale University School Of Medicine and has been its Senior Vice President of Information Systems September 30, 2015. He serves as Chief Information Officer of Technology ...
Seasoned executive problem solver with extensive C-level experience across a wide range of industries, organizations, and disciplines. Role model idea practitioner and strong team builder. Proven transformational leader. Experience as a technology executive (CIO and CTO), general management executive (COO, CEO, VP) and consulting partner. Published author and frequent conference speaker/panelist on business and technology strategy.
Stanford-trained PhD economist who loves building data products, end to end.
Currently works at CVS-Aetna as VP of Data Science, focusing on clinical products. This role focused on forming the product vision, cultivating client relationships, and managing technical development. Previously, spent five years at the health analytics startup Nuna, where directed the data science team, and helped building a product that matches new Medicaid members to primary care doctors based on personalized information.
Nick worked as an analyst in the equity strategy department of Danske Bank, prior to joining Fortis Investments (now part of BNP Paribas Asset Management) as a quantitative analyst focussing on systematic long-only and long/short strategies in cash equities. He subsequently worked as a data scientist roles for Infosys and ThinkBig Analytics, having served most recently as the head of research for a start-up asset manager in London.
UK trained Physician with a background in both Medicine and Surgery and a number of years ofstrategy and project management experience. Currently head the clinical team at Rx.Health includingleading clinical strategy and project deployment at Rx.Health.
Digital transformation leader in health care and consumer products. Expertise in product market fit,strategic partnerships and scaling high growth businesses.
This event starts on May 16th at 6:00 PM.